why ENDRA Life Sciences Inc [NDRA] is a Good Choice for Investors After New Price Target of $8.00

ENDRA Life Sciences Inc [NASDAQ: NDRA] jumped around 0.01 points on Monday, while shares priced at $0.06 at the close of the session, up 11.82%.

Compared to the average trading volume of 22.08M shares, NDRA reached a trading volume of 22713705 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

What do top market gurus say about ENDRA Life Sciences Inc [NDRA]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for NDRA shares is $8.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on NDRA stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

The Average True Range (ATR) for ENDRA Life Sciences Inc is set at 0.01 The Price to Book ratio for the last quarter was 0.17, with the Price to Cash per share for the same quarter was set at 0.02.

How has NDRA stock performed recently?

ENDRA Life Sciences Inc [NDRA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -15.47. With this latest performance, NDRA shares dropped by -38.40% in over the last four-week period, additionally sinking by -95.27% over the last 6 months – not to mention a drop of -95.80% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NDRA stock in for the last two-week period is set at 31.60, with the RSI for the last a single of trading hit 31.09, and the three-weeks RSI is set at 31.92 for ENDRA Life Sciences Inc [NDRA]. The present Moving Average for the last 50 days of trading for this stock 0.0981, while it was recorded at 0.0621 for the last single week of trading, and 0.7217 for the last 200 days.

ENDRA Life Sciences Inc [NDRA]: Deeper insight into the fundamentals

ENDRA Life Sciences Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.04 and a Current Ratio set at 1.04.

Insider trade positions for ENDRA Life Sciences Inc [NDRA]

The top three institutional holders of NDRA stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in NDRA stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in NDRA stock with ownership which is approximately 5.1238%.

Most Popular